Trimethylamine production

Two people can eat the same meal and produce different amounts of trimethylamine, or TMA. Their gut microbes help explain that difference. But the amount of the downstream compound TMAO in their blood also depends on liver processing, kidney clearance and what was already present in the food.

This stool result estimates your microbial community's genetic potential to produce TMA. It comes from shotgun DNA sequencing, which examines microbial genes across the sample. It does not measure a chemical concentration of TMA or how much your gut produces each day. This is an exploratory marker: there are no validated clinical thresholds, and trials have not shown that using this result to guide treatment prevents heart or kidney disease.

What Your Gut Bacteria Are Doing

Gut bacteria can make TMA from choline, carnitine and betaine. These nutrients occur in both animal and plant foods. Eggs and liver are rich in choline, while red meat is a major source of carnitine. The amount reaching the microbes and the pathways those microbes carry both affect production.

One route uses the enzyme choline TMA-lyase. The cutC gene provides instructions for this enzyme, and cutD provides instructions for a protein that activates it. In one study of 50 human stool samples, cutC was detected in every sample, although bacteria carrying the relevant genes usually represented less than 1% of the community. Finding the gene is therefore common and does not by itself identify a health problem.

Carnitine can reach TMA through several routes. The cntA and cntB route needs oxygen; cntA was detected in about a quarter of the stool samples in that study. Other microbes use pathways that work without oxygen, including a route through gamma-butyrobetaine. Looking only for cntA would miss part of the community's capacity.

These functions are spread across different bacterial species and strains. A species associated with higher blood TMAO is not necessarily making TMA itself. It may participate in a shared pathway or tend to occur alongside organisms that do.

Why Genes Do Not Equal Output

A gene can be present without being active. Nutrient availability, conditions inside the gut and interactions between microbes affect how much TMA is produced. In a randomized dietary crossover study of 113 adults, stool microbial genes did not reliably predict diet-induced TMAO production. Enzyme activity measured in stool cultures also translated poorly to production measured in the person.

Chemical measurement of TMA in stool answers a different question. That concentration reflects what remains after production, absorption and microbial consumption. It is not a production rate either, and it cannot be substituted for this DNA-based estimate.

Some gut archaea can consume TMA and convert it into methane. Archaea are a separate group of microorganisms from bacteria. This has been demonstrated in laboratory studies, and human observational research links certain TMA-consuming archaea with lower fecal TMA. Their activity helps explain why production potential and the amount of TMA left in stool can differ. It does not establish that carrying these organisms lowers your cardiovascular risk.

From the Gut to the Bloodstream

TMA absorbed from the intestine reaches the liver, where the enzyme FMO3 converts it into trimethylamine N-oxide, or TMAO. The kidneys remove circulating TMAO. Fish can also supply TMAO directly, so a blood result does not depend entirely on microbial TMA production.

Most of the clinical outcome evidence discussed here concerns TMAO measured in plasma or serum. That is a different compound in a different specimen from the microbial production potential estimated by this stool test.

Heart Events and Mortality

In the Multi-Ethnic Study of Atherosclerosis, about 6,800 adults were followed for nearly 17 years. Higher plasma TMAO was associated with higher mortality after adjustment for demographic, lifestyle, dietary and metabolic factors. An increase spanning the midpoints of the lowest and highest fifths of TMAO was associated with about 12% higher mortality. The corresponding association with kidney failure death was about 44% higher, though that analysis included only 32 kidney failure deaths.

Among 1,208 people with chronic heart failure after a heart attack, those in the highest quarter of plasma TMAO had about three times the rate of major cardiac events as those in the lowest quarter before adjustment. After accounting for conventional risk factors, kidney filtration, a heart failure marker and inflammation, the rate remained about 57% higher.

A meta-analysis of seven prospective heart failure studies found roughly two-thirds higher risks of major cardiac events and death in the highest third of circulating TMAO compared with the lowest third. Results differed substantially between studies. These are relative associations in people with heart failure, not estimates of what a particular stool result means for you.

An umbrella review of 82 studies found highly suggestive evidence linking circulating TMAO with several outcomes, including major cardiovascular events, mortality, hypertension, diabetes and reduced kidney filtration. That rating describes the strength of observational evidence. It does not establish that lowering TMAO prevents those outcomes.

Animal and cell experiments provide plausible mechanisms involving cholesterol accumulation in artery walls, inflammation and increased activity of blood-clotting platelets. In one study, transferring human gut microbial communities into mice changed experimental stroke severity through this pathway. Those experiments support biological plausibility, but they do not validate this stool score as a predictor of human stroke.

Why Kidney Function Matters

Blood TMAO tends to rise as kidney filtration falls. A meta-analysis found that higher circulating TMAO was associated with about 26% higher mortality in people with chronic kidney disease who were not receiving dialysis, comparing higher with lower concentrations across the included studies.

Adjusting for kidney function weakens some associations between TMAO and cardiovascular outcomes. Kidney disease can also change the gut microbial community. Measuring microbial DNA in stool avoids directly measuring a substance retained in the blood, but it does not remove kidney disease as a source of biological differences. Combining a stool result with blood TMAO cannot cleanly separate increased production from impaired clearance.

What Studies in Diabetes and Obesity Show

Small studies of people with type 2 diabetes and advanced kidney disease have found differences in stool bacteria alongside higher serum TMAO and markers associated with inflammation or intestinal barrier disturbance. These comparisons do not establish that a particular microbial production score diagnoses a damaged gut barrier.

A study of early diabetic kidney disease linked TMA measured in urine with urinary albumin and differences in stool bacteria. Urinary TMA is a different measurement from stool production potential, so the finding cannot be used to interpret this result as evidence of kidney damage.

One study of children and adolescents measured TMA chemically in stool. Concentrations were higher in participants with obesity than in normal-weight participants and correlated with body mass index. The overweight group did not show the same statistically significant difference. This was an observational comparison, not a trial showing that fiber lowered TMA.

Other small studies have associated chemically measured fecal TMA with particular bacteria in older adults with cardiovascular disease and with periodontitis. They add evidence that this chemistry varies with health and microbial composition. They do not establish a disease threshold for the DNA-based production estimate.

Why Lower Does Not Automatically Mean Healthier

Some studies have found lower circulating TMAO in active ulcerative colitis or after large-artery atherosclerotic stroke. An exploratory study also found that plasma TMAO did not clearly distinguish early overweight or metabolic syndrome from healthy controls. These findings concern blood TMAO and different clinical settings. They do not demonstrate that low stool production potential signals a damaged microbial community, or that a higher result is protective.

There is no validated optimum for this stool marker. Microbial diversity, other predicted functions and measured stool inflammation can provide context, but combining them has not been shown to turn this result into a reliable estimate of heart or kidney risk.

How Stable Is the Result?

In a longitudinal study of 307 US men, microbial profiles showed some consistency across samples collected six months apart. Associations between red meat intake and plasma TMAO differed according to microbial composition. That does not establish a permanent producer classification or prove that this specific stool score is stable enough to support a fixed monitoring schedule.

When Results Can Be Misleading

• Potential versus activity: DNA shows which functions microbes may carry. It does not show whether those genes were active or how much TMA reached your circulation.
• Relative abundance: A larger share of TMA-producing organisms can reflect changes in other members of the community. It need not mean that the absolute number of producers increased.
• Diet and recent illness: Changes in food intake, bowel habits or illness can alter the microbial community. An unusual period may be poorly representative of your usual state.
• Antibiotics and bowel preparation: These can disturb the community being sampled. A result collected around treatment or colonoscopy may differ from your usual profile.
• Collection and handling: Contamination, inadequate sampling or departures from the kit's storage and shipping instructions can affect the microbial DNA recovered.
• Different methods: Shotgun sequencing, targeted gene measurements, stool chemical concentrations and blood TMAO measure different things. Sequencing depth, reference databases and analysis methods also affect estimates, so results from different services are not directly interchangeable.